Casos Clínicos |
El tumor pardo representa el estadío o etapa terminal de la patología óseo-dependiente del hiperparatiroidismo. Los cambios varían desde la desmineralización generalizada hasta la reabsorción ósea y sustitución por tejido fibroso con cambios quísticos. La lesión clásica es la osteítis fibrosa quística, el tumor pardo de mandíbula está asociado al carcinoma de paratiroides en lugar de adenoma. Además existe asociación con adenoma atípico de paratiroides, lesión no carcinomatosa pero que posee algunas características microscópicas en común. Palabras Claves: Tumor pardo, adenoma, hiperparatiroidismo. |
|
Abstract: | |
Introduction.- Gastric carcinoma is one of the most common malignancies in the world. In Peru it is the most common malignant disease in men and the third most common in women, being the first cause of death. This paper aims to identify key risk factors for postoperative morbidity in advanced gastric carcinoma after D2 lymphadenectomy.
Material and Methods.- Study of cases and controls. We evaluated 76 patients record (census sample) with advanced gastric carcinoma undergoing D2 lymphadenectomy gastrectomy served from January 1991 to December 2008 in the Department of Surgery, Hospital Belén de Trujillo - Peru
Results.- We identified 76 patients with gastrectomy and lymphadenectomy D2, with an averange age of 59.99 years old. The population
was divided into cases (29 patients) and controls (47 patients). We found as risk factors: total gastrectomy (odds ratio 8.57, p = 0.02 (95% CI: 1.67 - 43.91), ASA III and IV (odds ratio 3.43, p= 0.0172187 (95% CI 1.09 - 10.89). Clinical stage histological type, size, and location of tumor were not risk factors. |
Autor(es) : Dr. Carlos Bueno, Dr. Carlos Paula, Dr. Leopoldo García, Dr. Napoleón Benitez, Md. Diego Vivar,
Para ver el contenido completo en PDF debe estar registrado